Description
Fentanyl Powder Indications and Usage for Fentanyl Lozenge
Fentanyl Powder Oral transmucosal fentanyl citrate. The is an opioid agonist indicate for the management of breakthrough pain in cancer.
to around-the-clock opioid therapy for their underlying persistent cancer pain.
Patients considered opioid tolerant are those who are taking, for one week or longer.
around-the-clock medicine consisting of at least 60 mg of oral morphine per day.
Patients must remain on around-the-clock opioids while taking oral transmucosal fentanyl citrate.
Not for use in opioid non-tolerant patients.
Not for use in the management of acute or postoperative pain, including headache/migraine or dental pain. As a part of the TIRF REMS, oral transmucosal fentanyl citrate may be dispense by outpatient pharmacie only to outpatient enrolle in the program. For inpatient administration of oral transmucosal fentanyl citrate, patient and prescriber enrollment are not required.
Indications and Usage for Fentanyl Lozenge
Oral transmucosal fentanyl citrate is indicated for the management of breakthrough pain in cancer patients 16 years of age and older who are already receiving and who are tolerant to around-the-clock opioid therapy for their underlying persistent cancer pain.
Fentanyl Lozenge Dosage and Administration
Healthcare professionals who prescribe oral transmucosal fentanyl citrate for outpatients must enroll in the TIRF REMS and comply with the requirements of the REMS to ensure safe use of oral transmucosal fentanyl citrate [see Warnings and Precautions .
Use the lowest effective dosage for the shortest duration consistent with individual patient treatment goals [see Warnings and Precautions .
It is important to minimize the number of strengths available to patients at any time to prevent confusion and possible overdose.
Initiate the dosing regimen for each patient individually, taking into account the patient’s severity of pain, patient response, prior analgesic treatment experience, and risk factors for addiction, abuse, and misuse [see Warnings and Precautions.
Initial Dosage
Individually titrate oral transmucosal fentanyl citrate to a dose that provides adequate analgesia and minimizes side effects. The initial dose of oral transmucosal fentanyl citrate to treat episodes of breakthrough cancer pain is always 200 mcg. The oral transmucosal fentanyl citrate unit shoul be consume over 15 minute.
Reviews
There are no reviews yet.